This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Waldemar Kolanus: Innovator in Cytohesin-PH Peptides
Introduction
Waldemar Kolanus is a notable inventor based in München, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that influence integrin adhesion.
Latest Patents
Kolanus holds a patent for Cythohesin-PH peptides that affect the ability of integrins to adhere. This patent describes isolated cytohesin-PH peptides that can inhibit beta-2 integrins from adhering. The cytohesin-PH peptide features an amino acid sequence that comprises approximately a 140 amino acid domain from cytohesin-2. Additionally, assay kits that include these peptides are also provided.
Career Highlights
Waldemar Kolanus is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work has focused on innovative solutions that address critical biological processes.
Collaborations
Kolanus collaborates with Britta Ostner, contributing to advancements in their shared field of research.
Conclusion
Waldemar Kolanus is a distinguished inventor whose work on cytohesin-PH peptides has the potential to impact medical and scientific communities significantly. His contributions continue to pave the way for future innovations in integrin research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile